ctrl K

Price Alert

Aethlon Medical Inc. (AEMD)

NASDAQ: AEMD · Real-Time Price · USD

1.15

-0.02 (-1.71%)

At close: Aug 15, 2025, 3:50 PM

Aethlon Medical Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	n/a	n/a	574.25K	294.17K	659.1K
Cost of Revenue	339.56K	359.06K	n/a	154.22K	n/a
Gross Profit	-339.56K	-359.06K	574.25K	294.17K	659.1K
Operating Income	-9.34M	-12.64M	-11.9M	-10.42M	-7.89M
Interest Income	298.12K	428.39K	10.97K	n/a	n/a
Pretax Income	-13.39M	-12.21M	-12.03M	-10.42M	-7.89M
Net Income	-13.39M	-12.21M	-12.03M	-10.42M	-7.89M
Selling & General & Admin	3.24M	9.76M	12.47M	10.71M	8.55M
Research & Development	2.21M	2.52M	2.75M	2.34M	2.07M
Other Expenses	3.89M	n/a	-2.75M	-2.34M	-2.07M
Operating Expenses	9.34M	12.28M	12.47M	10.71M	8.55M
Interest Expense	10.11K	n/a	n/a	n/a	1.58K
Selling & Marketing Expenses	n/a	-7.42B	4.96M	5.03M	3.65M
Cost & Expenses	9.34M	12.64M	12.47M	10.71M	8.55M
Income Tax Expense	n/a	n/a	n/a	-4.8K	-6.37K
Shares Outstanding (Basic)	1.56M	2.51M	2.05M	1.48M	1.21M
Shares Outstanding (Diluted)	1.56M	2.51M	2.05M	1.48M	1.21M
EPS (Basic)	-8.58	-4.86	-5.86	-7.06	-6.52
EPS (Diluted)	-8.58	-4.86	-5.86	-7.06	-6.52
EBITDA	-13.04M	-11.85M	-11.66M	-10.3M	-7.85M
EBIT	-13.38M	-12.21M	-11.9M	-10.42M	-7.89M
Depreciation & Amortization	339.56K	359.06K	240.89K	123.69K	39.94K